2-(1,3-Benzothiazol-2-yl)-1-phenylethan-1-one, 97%, 1g

7-Fluoroindole, 97.0%, 10g

2-Methoxy-5-(trifluoromethyl)benzeneboronic acid, 97.0%, 1g

2-Bromo-5-chloro-3-methoxy-pyrazine, 97%, 100mg

Xylène (isomères), 2,5 l, verre

DBCO-CONH-S-S-NHS ester, 25mg

3,4-Dibromo-1-methyl-pyrazole, 98%, 500mg

Butyronitrile, 99.0%, 100g

3,5-Dichloro-2-ethylpyrazine, 97.0%, 250mg

(S)-N-(2-(4-(tert-Butyl)-4,5-dihydrooxazol-2-yl)phenyl)-1-phenylmethanesulfonamide, 97.0%, 1g

(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-(3,4-dihydroxyphenyl)propanoate, 95.0%, 5g

{1-[(5-methyl-2-furyl)methyl]-3-oxo-2-piperazinyl}acetic acid, 95.0%, 1g

(2E)-3-(4-ethylphenyl)-1-(4-methylphenyl)prop-2-en-1-one, 95.0%, 10g